Novasep (Lyon, France) has announced a €6.1 million investment in its Mourenx site, Pyrénées-Atlantiques, France, to modernize its API manufacturing facility.
The modernization of the cGMP workshop includes the installation of new equipment and the revamping of clean rooms for API isolation, enhancing Novasep’s flexibility and developing capacity for the custom manufacturing of innovative therapeutic molecules. Additionally, Novasep has also announced the creation of seven full-time jobs on this site.
This project has been selected as part of the France Relance recovery plan initiated by the French government. Novasep will be supported within the framework of the “Investissements d’Avenir” (Investments for the future) programme, which rewards innovative and promising industrial investments.
“This investment sends a strong signal to our customers and partners by increasing our market competitiveness. It further supports our strategy of reinforcing our high-quality offer for the commercial production of innovative therapies,” said Michel Spagnol, Chairman and CEO of Novasep.
For more information please visit: www.novasep.com
Inside the Laboratory: The Chromatography Laboratory at the University of Rouen
April 18th 2024In this edition of “Inside the Laboratory,” Pascal Cardinael and Valérie Agasse of the University of Rouen in Mont‑Saint-Aignan, France, discuss their laboratory’s work with miniaturizing gas chromatography (GC) columns and systems to improve on-site air analysis of volatile organic compounds (VOCs).